Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
Tarih
2021Yazar
Guzel, Deniz Kamalak
Tuna, Nazan
Kinikli, Sami
İNAN, DİLARA
ERSÖZ, GÜLDEN
Simsek, Funda
Tulek, Necla
Tarakci, Huseyin
YILDIZ, ORHAN
Turkoglu, Emine
Simsek, Sumeyra
Batirel, Ayse
URAL, ONUR
Barut, Sener
Kuruuzum, Ziya
Sener, Alper
Ozel, Selcan Arslan
Ozturk, Sinan
Suer, Kaya
ÇELEN, MUSTAFA KEMAL
Konya, Petek
Asan, Ali
SALTOĞLU, Neşe
Dogan, Nurhan
AKHAN, SILA
Mistik, Resit
Celik, Ilhami
AYGEN, BİLGEHAN
Demirturk, Nese
SİLİ, ULUHAN
KORKMAZ, PINAR
Ormen, Bahar
Ertem, Gunay Tuncer
Hakyemez, Ismail Necati
KARAKEÇİLİ, FARUK
Cetinkaya, Riza Aytac
Cagatay, Atahan
DEMİR, NAZLIM AKTUĞ
Turker, Nesrin
BİLGİN, HÜSEYİN
Gurbuz, Yunus
Üst veri
Tüm öğe kaydını gösterÖzet
Background: In this study, we aimed to investigate the efficacy and safety of sofosbuvir-based therapies in the treatment of chronic hepatitis C in real-world clinical practice.
Koleksiyonlar
- Makale [92796]